IGF2BP2 and nasopharyngeal carcinoma: In our study, we individually knocked down YTHDF1/2/3 and IGF2BP1/2/3 in two NPC cell lines and observed that only knockdown of IGF2BP2 significantly inhibited the protein level of ANKRD22 (Figure 5A and Figure S6A).